The small leucine-rich proteoglycan lumican, for instance, inhibits and even reverses some of the characteristics of EMT, such as invadopodia formation, suggesting lumican as a marker for staging of several cancers and the development of cancer drugs based on lumican [414,415]. Here, LUM is linked to cancer.